BEDFORD, Mass., Nov. 11, 2009 /PRNewswire-FirstCall/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Jack Cumming, Chairman, will present at the NASDAQ OMX 23rd Investor Program in London on Tuesday, December 1, 2009, at 11:15am (GMT).
Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on the investor section of the company's website at www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.
Vice President, Investor Relations